211
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Reducing the Histopathological Changes of Radioiodine to the Lacrimal Glands by a Popular Anti-Oxidant: Lycopene

, , , , , , & show all
Pages 659-665 | Received 08 Aug 2013, Accepted 14 Nov 2013, Published online: 28 May 2014

REFERENCES

  • Lee SL. Radioactive iodine therapy. Curr Opin Endocrinol Diabetes Obes 2012;19:420–428
  • Wartorsky L, Van Nostrand D. Radioiodine treatment of well-differentiated thyroid cancer. Endocrine 2012;42:506–513
  • Silberstein EB. Reducing the incidence of 131I-induced sialadenitis: the role of pilocarpine. J Nucl Med 2008;49:546–549
  • Cavalieri RR. Iodine metabolism and thyroid physiology: current concepts. Thyroid 1997;7:177–181
  • Bohuslaviziki KH, Brenner W, Lassmann S, Tinnemeyer S, Tönshoff G, Sippel C, et al. Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine. Nucl Med Commun 1996;17:681–686
  • Solans R, Bosch JA, Galofré P, Porta F, Roselló J, Selva-O'Callagan A, et al. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med 2001;42:738–743
  • Zettinig G, Hanselmayer G, Fueger BJ, Hofmann A, Pirich C, Nepp J, et al. Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study. Eur J Nucl Med Mol Imaging 2002;29:1428–1432
  • Koca G, Acar U, Atilgan HI, Erginturk Acar D, Altiparmak UE, Demirel K, et al. Changes in conjunctival cytology and tear function tests with radioiodine treatment for hyperthyroidism. Ann Nucl Med 2013;27:694–699
  • Capizzi RL, Oster W. Chemoprotective and radioprotective effects of amifostine: an update of clinical trials. Int J Hematol 2000;72:425–435
  • Bohuslavizki KH, Klutmann S, Jenicke L, Brenner W, Feyerabend B, Henze E, et al. Radioprotection of salivary glands by S-2-(3-aminopropylamino)-ethylphosphorothioic (amifostine) obtained in a rabbit animal model. Int J Radiat Oncol Biol Phys 1999;45:181–186
  • Liu B, Kuang A, Huang R, Zhao Z, Zeng Y, Wang J, et al. Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial. J Nucl Med 2010;51:618–623
  • Koca G, Yalniz-Akkaya Z, Gultekin SS, Yumusak N, Demirel K, Korkmaz M, et al. Radioprotective effect of montelukast sodium in rat lacrimal glands after radioiodine treatment. Rev Esp Med Nucl Imagen Mol 2013;32:294–300
  • Spitzweg C, Joba W, Schriever K, Goellner JR, Morris JC, Heufelder AE. Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. J Clin Endocrinol Metab 1999;84:4178–4184
  • Choi SK, Seo JS. Lycopene supplementation suppresses oxidative stress induced by a high fat diet in gerbils. Nutr Res Pract 2013;7:26–33
  • Kapitanov AB, Pimenov AM, Obukhova LK, Izmaîlov DM. Radiation-protective effectiveness of lycopene. Radiats Biol Radioecol 1994;34:439–445
  • Meydan D, Gursel B, Bilgici B, Can B, Ozbek N. Protective effect of lycopene against radiation-induced hepatic toxicity in rats. J Int Med Res 2011;39:1239–1252
  • Cavusoglu K, Yalcin E. Radioprotective effect of lycopene on chromosomal aberrations (CAs) induced by gamma radiation in human lymphocytes. J Environ Biol 2009;30:113–117
  • Srinivasan M, Devipriya N, Kalpana KB, Menon VP. Lycopene: an antioxidant and radioprotector against gamma-radiation-induced cellular damages in cultured human lymphocytes. Toxicology 2009;262:43–49
  • Damato BE, Allan D, Murray SB, Lee WR. Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease. Br J Ophthalmol 1984;68:674–680
  • Rios JD, Horikawa Y, Chen LL, Kublin CL, Hodges RR, Dartt DA, et al. Age-dependent alterations in mouse exorbital lacrimal gland structure, innervation and secretory response. Exp Eye Res 2005;80:477–491
  • Markitziu A, Lustmann J, Uzieli B, Krausz Y, Chisin R. Salivary and lacrimal gland involvement in a patient who had undergone a thyroidectomy and was treated with radioiodine for thyroid cancer. Oral Surg Oral Med Oral Pathol 1993;75:318–322
  • Cavusoglu T, Nurozler AB, Titiz C, Ustun H, Aral Y, Ozer E, et al. Tear function and ocular surface changes in multinodular goiter patients. Ophthalmologica 2007;221:264–268
  • Alexander C, Bader JB, Schaefer A, Finke C, Kirsch CM. Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma. J Nucl Med 1998;39:1551–1554
  • Fard-Esfahani A, Mirshekarpour H, Fallahi B, Eftekhari M, Saghari M, Beiki D, et al. The effect of high-dose radioiodine treatment on lacrimal gland function in patients with differentiated thyroid carcinoma. Clin Nucl Med 2007;32:696–699
  • Nagler RM. Effects of head and neck radiotherapy on major salivary glands-animal studies and human implications. In Vivo 2003;17:369–375
  • Konings AW, Coppes RP, Vissink A. On the mechanism of salivary gland radiosensitivity. Int J Radiat Oncol Biol Phys 2005;62:1187–1194
  • Blokhina O, Virolainen E, Fagerstedt KV. Antioxidants, oxidative damage and oxygen deprivation stress: a review. Ann Bot 2003;91:179–194
  • Lauretani F, Semba RD, Dayhoff-Brannigan M, Corsi AM, Di Iorio A, Buiatti E, et al. Low total plasma carotenoids are independent predictors of mortality among older persons: the InCHIANTI study. Eur J Nutr 2008;47:335–340
  • Omoni AO, Aluko RE. The anti-carcinogenic and anti-atherogenic effects of lycopene: a review. Trends Food Sci Technol 2005;16:344–350
  • Ma C, Xie J, Jiang Z, Wang G, Zuo S. Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 2010;37:1778–1785
  • Mandel SJ, Mandel L. Radioactive iodine and the salivary glands. Thyroid 2003;13:265–271

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.